Hosted on MSN

HSBC Upgrades Eli Lilly (LLY) to Hold, Lifts Price Target to $700

Eli Lilly and Company (NYSE: LLY ) is one of the best stocks for a 20-year long-term stock portfolio . Eli Lilly has substantially underperformed this year with YTD decline of over 5%. On August 8, ...
Nasdaq

Goldman Sachs Upgrades Eli Lilly and (BMV:LLY)

Fintel reports that on April 8, 2025, Goldman Sachs upgraded their outlook for Eli Lilly and (BMV:LLY) from Neutral to Buy. Lilly Endowment holds 96,892K shares representing 10.79% ownership of the ...
Nasdaq

Deutsche Bank Upgrades Eli Lilly and (LLY)

Fintel reports that on August 12, 2024, Deutsche Bank upgraded their outlook for Eli Lilly and (NYSE:LLY) from Hold to Buy. As of August 5, 2024, the average one-year price target for Eli Lilly and is ...
Insider Monkey

Erste Group Upgrades Eli Lilly (LLY) to Buy Following Strong First-Half Results

Eli Lilly and Company (NYSE:LLY) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) is an American multinational pharmaceutical company. The ...
Seeking Alpha

Eli Lilly: Buying Opportunity Knocking On The Front Door Again (Rating Upgrade)

I think it’s sufficient for me to say that investors in Eli Lilly and Company (LLY) really needed this strong earnings slate that it delivered for Q1. That semblance of normalcy, the calm and ...